Regional Account Manager - NYC/Philadelphia/Baltimore
AbbottSalary not specified
- Full Time
- Junior (1 to 2 years)
Axsome Therapeutics Inc
Regional Account Manager- Neurology (Great Plains Area based candidates)
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries
Requirements
Candidates must hold a Bachelor’s degree, with preferred degrees in life sciences, business, or healthcare, and possess a minimum of 5 years of pharmaceutical, biotech, or healthcare sales experience, including at least 3 years of experience in rare disease or orphan drug sales. They should have a proven track record of exceeding sales targets and successfully managing a territory, along with experience selling high-cost products through specialty pharmacies.
Responsibilities
The Regional Account Manager will be responsible for representing PTC’s products to medical professionals specializing in neurological diseases and/or Friedreich's Ataxia (FA) within their assigned region, achieving assigned sales targets, implementing marketing strategies, collaborating with internal and external teams, developing business partnerships with physicians and healthcare staff, identifying key treatment centers, cultivating relationships with patient advocacy groups, employing a consultative sales approach, addressing product access and reimbursement issues, and performing additional tasks as needed.
Skills
Pharmaceutical sales
Neurology
Friedreich's Ataxia
Relationship building
Healthcare education
Regulatory compliance
Marketing strategy
Cross-functional collaboration
Patient engagement
Solution-oriented sales
Axsome Therapeutics Inc
Develops therapies for CNS disorders
About Axsome Therapeutics Inc
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.
Key Metrics
New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees